title: Activated androgen receptor downregulates E-cadherin gene expression and promotes tumor metastasis.
abstract: The loss of E-cadherin gene expression can cause the dysfunction of the cell-cell junction to trigger tumor metastasis. Members of the Snail family of transcription factors are repressors of the expression of the E-cadherin gene. In this study, we showed that the activated androgen receptor (AR) is a novel repressor of E-cadherin gene expression and can promote metastasis. Our results demonstrated that the activated AR could bind to the E-cadherin promoter in vitro and in vivo. The activated AR and HDAC1 had synergistic effects in downregulating E-cadherin gene expression. Treating cells with the AR ligand, dihydrotestosterone (DHT), triggered the reduction of E-cadherin expression and induced changes in cell morphology from an epithelial-like to a mesenchymal-like appearance. When nonmetastatic breast cancer cells expressing cytoplasmic AR were transplanted into mice and the mice were treated with DHT, tumors were detected at metastatic sites, whereas no tumors were detected in transplanted mice without DHT treatment. Furthermore, clinical data from breast cancer patients with invasive ductal carcinomas showed high levels of AR expression in the nuclei and low levels of E-cadherin expression. These results suggest that, similarly to Snail and Twist, the activated AR can downregulate E-cadherin expression to promote the activation of epithelial-mesenchymal transition and tumor metastasis.
authors.affiliation: Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan.
authors.forename: Yan-Nian
authors.initials: YN
authors.lastname: Liu
authors.forename: Ying
authors.initials: Y
authors.lastname: Liu
authors.forename: Han-Jung
authors.initials: HJ
authors.lastname: Lee
authors.forename: Yung-Hsiang
authors.initials: YH
authors.lastname: Hsu
authors.forename: Ji-Hshiung
authors.initials: JH
authors.lastname: Chen
mesh_terms: D000818:Animals; D015820:Cadherins / Q000032:analysis / Q000235:genetics*; D018270:Carcinoma, Ductal, Breast / Q000737:chemistry; D045744:Cell Line, Tumor; D013196:Dihydrotestosterone / Q000494:pharmacology; D015536:Down-Regulation; D004847:Epithelial Cells / Q000166:cytology; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D059630:Mesenchymal Stem Cells / Q000166:cytology; D051379:Mice; D009362:Neoplasm Metastasis / Q000473:pathology*; D009363:Neoplasm Proteins / Q000032:analysis; D009374:Neoplasms, Experimental / Q000473:pathology; D011401:Promoter Regions, Genetic; D011485:Protein Binding; D011944:Receptors, Androgen / Q000032:analysis / Q000378:metabolism / Q000502:physiology*; D014183:Transplantation, Heterologous; D014407:Tumor Cells, Cultured
chemical_list: C410798:AR protein, human; D015820:Cadherins; D009363:Neoplasm Proteins; D011944:Receptors, Androgen; D013196:Dihydrotestosterone
references.citation: Oncogene. 1999 Jul 29;18(30):4301-12
references.pmid: 10439038
references.citation: Cell. 2006 Feb 10;124(3):615-29
references.pmid: 16469706
references.citation: Proc Natl Acad Sci U S A. 2006 Feb 28;103(9):3100-5
references.pmid: 16492776
references.citation: J Biol Chem. 2004 Jul 9;279(28):29436-49
references.pmid: 15123687
references.citation: Cancer. 2003 Aug 15;98(4):703-11
references.pmid: 12910513
references.citation: Cancer Lett. 1998 Feb 13;124(1):95-103
references.pmid: 9500197
references.citation: Oncogene. 2005 Dec 15;24(56):8277-90
references.pmid: 16116478
references.citation: Endocrinology. 2006 Jan;147(1):590-8
references.pmid: 16210365
references.citation: Cancer Res. 2005 Jun 15;65(12):5445-53
references.pmid: 15958594
references.citation: Nat Rev Mol Cell Biol. 2000 Nov;1(2):91-100
references.pmid: 11253370
references.citation: Cell. 2006 Nov 17;127(4):679-95
references.pmid: 17110329
references.citation: Nat Cell Biol. 2000 Feb;2(2):84-9
references.pmid: 10655587
references.citation: Physiol Rev. 2003 Apr;83(2):337-76
references.pmid: 12663862
references.citation: Trends Genet. 1993 Sep;9(9):317-21
references.pmid: 8236461
references.citation: Mol Cell Biol. 2004 Jan;24(1):306-19
references.pmid: 14673164
references.citation: Curr Opin Cell Biol. 1993 Oct;5(5):806-11
references.pmid: 8240824
references.citation: Breast Cancer Res. 2003;5(3):164-73
references.pmid: 12793900
references.citation: Nat Rev Cancer. 2002 Jul;2(7):521-8
references.pmid: 12094238
references.citation: J Cell Biol. 1991 Apr;113(1):173-85
references.pmid: 2007622
references.citation: Nat Rev Cancer. 2003 Jun;3(6):453-8
references.pmid: 12778135
references.citation: Cancer. 1996 Apr 15;77(8 Suppl):1605-13
references.pmid: 8608551
references.citation: Proc Natl Acad Sci U S A. 1982 May;79(9):2957-61
references.pmid: 6953441
references.citation: Endocr Relat Cancer. 2003 Dec;10(4):537-60
references.pmid: 14713266
references.citation: Biochim Biophys Acta. 1994 May 27;1198(1):11-26
references.pmid: 8199193
references.citation: J Cell Sci. 2004 Aug 15;117(Pt 18):4277-87
references.pmid: 15292402
references.citation: J Biol Chem. 2001 Jul 20;276(29):27424-31
references.pmid: 11309385
references.citation: Genes Dev. 2006 Apr 1;20(7):784-94
references.pmid: 16600910
references.citation: Cancer Res. 1995 Nov 15;55(22):5195-9
references.pmid: 7585573
references.citation: J Nucl Med. 1997 Mar;38(3):402-9
references.pmid: 9074528
references.citation: Nature. 2007 Aug 2;448(7153):547-8
references.pmid: 17671495
references.citation: Cancer Res. 2008 Feb 15;68(4):1128-35
references.pmid: 18281488
references.citation: Genes Dev. 2007 Aug 15;21(16):2005-17
references.pmid: 17699749
references.citation: J Steroid Biochem Mol Biol. 2004 Nov;92(4):221-36
references.pmid: 15663986
references.citation: Trends Biochem Sci. 1999 Feb;24(2):73-6
references.pmid: 10098402
references.citation: Nat Cell Biol. 2000 Feb;2(2):76-83
references.pmid: 10655586
references.citation: FASEB J. 2002 Sep;16(11):1444-6
references.pmid: 12205042
references.citation: Nat Rev Cancer. 2002 Jun;2(6):442-54
references.pmid: 12189386
references.citation: Lancet. 1996 May 18;347(9012):1377-81
references.pmid: 8637346
references.citation: Cell. 1980 Feb;19(2):465-71
references.pmid: 7357614
references.citation: EMBO J. 1988 Dec 1;7(12):3679-84
references.pmid: 3061804
references.citation: Oncogene. 2004 Apr 15;23(17):3059-66
references.pmid: 14981544
references.citation: Int J Dev Biol. 2004;48(5-6):365-75
references.pmid: 15349812
references.citation: Nature. 2000 Jan 6;403(6765):41-5
references.pmid: 10638745
references.citation: Nucleic Acids Res. 2005 Jan 07;33(1):13-26
references.pmid: 15640443
references.citation: Cell. 2000 Jan 7;100(1):57-70
references.pmid: 10647931
references.citation: Cell. 2004 Jun 25;117(7):927-39
references.pmid: 15210113
references.citation: Biochemistry. 1979 Nov 27;18(24):5294-9
references.pmid: 518835
references.citation: Nat Rev Cancer. 2002 Aug;2(8):563-72
references.pmid: 12154349
references.citation: Eur Urol. 1998 Dec;34(6):505-11
references.pmid: 9831793
references.citation: Neoplasia. 2003 Jul-Aug;5(4):347-61
references.pmid: 14511406
references.citation: Urology. 2003 Nov;62(5 Suppl 1):3-10
references.pmid: 14607212
references.citation: J Cell Sci. 2003 Feb 1;116(Pt 3):499-511
references.pmid: 12508111
references.citation: Oncogene. 2001 Jun 28;20(29):3880-7
references.pmid: 11439351
references.citation: Nature. 2001 Mar 1;410(6824):50-6
references.pmid: 11242036
references.citation: Nat Genet. 2000 Sep;26(1):16-7
references.pmid: 10973239